Cargando…

Sustainability of Rituximab Therapy in Different Treatment Strategies: Results of a 3-Year Followup of a German Biologics Register

OBJECTIVE: To compare the approved treatment of rheumatoid arthritis using rituximab + methotrexate (RTX + MTX) versus the off-label treatment variants of RTX in monotherapy or RTX in combination with leflunomide (RTX + LEF). METHODS: We included RTX-naive patients enrolled in the German biologics r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Adrian, Strangfeld, Anja, Herzer, Peter, Wilden, Elke, Bussmann, Arnold, Listing, Joachim, Zink, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282041/ https://www.ncbi.nlm.nih.gov/pubmed/24664818 http://dx.doi.org/10.1002/acr.22327

Ejemplares similares

Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT
por: Gerhold, Kerstin, et al.
Publicado: (2015)

Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort
por: Baganz, Lisa, et al.
Publicado: (2017)

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
por: Strangfeld, Anja, et al.
Publicado: (2010)

Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low – results from RABBIT, the German biologics register
por: Listing, Joachim, et al.
Publicado: (2006)

Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort
por: Meissner, Y, et al.
Publicado: (2017)

Incidence of facial nerve palsies stratified by DMARD treatment in patients with rheumatoid arthritis: data from the RABBIT register
por: Meissner, Yvette, et al.
Publicado: (2020)

Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
por: Listing, Joachim, et al.
Publicado: (2015)

Mobile Responsive App—A Useful Additional Tool for Data Collection in the German Pregnancy Register Rhekiss?
por: Richter, Jutta G., et al.
Publicado: (2021)

Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
por: Strangfeld, A, et al.
Publicado: (2017)

Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, targeted synthetic and conventional synthetic DMARD treatment: data from the German RABBIT register
por: Redeker, Imke, et al.
Publicado: (2022)

Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis
por: Meissner, Yvette, et al.
Publicado: (2016)

Factors associated with treatment satisfaction in patients with rheumatoid arthritis: data from the biological register RABBIT
por: Schäfer, Martin, et al.
Publicado: (2020)

Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases
por: Albrecht, Katinka, et al.
Publicado: (2016)

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
por: Mercer, Louise K, et al.
Publicado: (2017)

Impact of treatment with biologic DMARDs on the risk of sepsis or mortality after serious infection in patients with rheumatoid arthritis
por: Richter, A, et al.
Publicado: (2016)

Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
por: Schäfer, Martin, et al.
Publicado: (2020)

Neues aus dem RABBIT-Register
por: Meißner, Yvette, et al.
Publicado: (2021)

Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register
por: Meissner, Yvette, et al.
Publicado: (2023)

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
por: Strangfeld, A, et al.
Publicado: (2011)

Evaluation of the RABBIT Risk Score for serious infections
por: Zink, A, et al.
Publicado: (2014)

Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA
por: Regierer, Anne Constanze, et al.
Publicado: (2023)

Biologicals and Biosimilars in Hematology: The Case of Rituximab
por: Vulto, Arnold G.
Publicado: (2019)

Implementing an automated monitoring process in a digital, longitudinal observational cohort study
por: Lindner, Lisa, et al.
Publicado: (2021)

33 Jahre DRFZ: Epidemiologie und Versorgungsforschung
por: Strangfeld, Anja, et al.
Publicado: (2022)

Maternal and infant outcomes in pregnancies of women with axial spondyloarthritis compared with matched controls: results from nationwide health insurance data
por: Redeker, Imke, et al.
Publicado: (2022)

STAR Caregivers: Virtual Training and Followup: Implementation
por: Penfold, Robert, et al.
Publicado: (2021)

Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
por: Protopopov, Mikhail, et al.
Publicado: (2017)

Extended followup of a cohort of chromium production workers
por: Gibb, Herman Jones, et al.
Publicado: (2015)

Focus on “The German TraumaRegister DGU(®) (TR-DGU)”
por: Lustenberger, Thomas, et al.
Publicado: (2020)

Increase in Registered Acute Kidney Injuries in German Hospitals
por: Matrisch, Ludwig, et al.
Publicado: (2023)

Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database
por: Albrecht, Katinka, et al.
Publicado: (2020)

Short-term followup after surgical treatment of Ewing’s sarcoma
por: Rastogi, Shishir, et al.
Publicado: (2010)

The Evaluation and Followup of Children Referred to Pediatric Endocrinologists for Short Stature
por: Wyatt, David, et al.
Publicado: (2010)

Controversies in the Management and Followup of Differentiated Thyroid Cancer: Beyond the Guidelines
por: Ahmadieh, Hala, et al.
Publicado: (2012)

Postcolonoscopy Followup Recommendations: Comparison with and without Use of Polyp Pathology
por: Ratuapli, Shiva K., et al.
Publicado: (2014)

Over 1-Year Followup of Laparoscopic Treatment of Enterovesical Fistula
por: Nevo, Yehonatan, et al.
Publicado: (2019)

European Network of Pregnancy Registers in Rheumatology (EuNeP)—an overview of procedures and data collection
por: Meissner, Yvette, et al.
Publicado: (2019)

Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years
por: Baraliakos, Xenofon, et al.
Publicado: (2013)

TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD
por: Regierer, Anne Constanze, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjp5r2f4egk4thoi5pjiv1fev3